1. Home
  2. CNXU vs ORMP Comparison

CNXU vs ORMP Comparison

Compare CNXU & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conexeu Sciences Inc. Common Stock

CNXU

Conexeu Sciences Inc. Common Stock

N/A

Current Price

$7.76

Market Cap

208.4M

Sector

Health Care

ML Signal

N/A

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

HOLD

Current Price

$4.39

Market Cap

170.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNXU
ORMP
Founded
N/A
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.4M
170.3M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
CNXU
ORMP
Price
$7.76
$4.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
134.1K
168.2K
Earning Date
N/A
05-14-2026
Dividend Yield
N/A
6.51%
EPS Growth
N/A
412.50
EPS
N/A
0.91
Revenue
N/A
$2,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.47
Revenue Growth
N/A
49.25
52 Week Low
$7.10
$1.98
52 Week High
$13.66
$5.19

Technical Indicators

Market Signals
Indicator
CNXU
ORMP
Relative Strength Index (RSI) 36.73 55.45
Support Level $7.62 $3.90
Resistance Level $11.51 $5.10
Average True Range (ATR) 1.25 0.18
MACD -0.08 0.01
Stochastic Oscillator 9.91 95.00

Price Performance

Historical Comparison
CNXU
ORMP

About CNXU Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

Share on Social Networks: